We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · April 23, 2021

Interim Estimates of Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines

MMWR. Morbidity and Mortality Weekly Report

 

Additional Info

Disclosure statements are available on the authors' profiles:

MMWR. Morbidity and Mortality Weekly Report
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021
MMWR Morb. Mortal. Wkly. Rep. 2021 Apr 02;[EPub Ahead of Print], MG Thompson, JL Burgess, AL Naleway, HL Tyner, SK Yoon, J Meece, LEW Olsho, AJ Caban-Martinez, A Fowlkes, K Lutrick, JL Kuntz, K Dunnigan, MJ Odean, KT Hegmann, E Stefanski, LJ Edwards, N Schaefer-Solle, L Grant, K Ellingson, HC Groom, T Zunie, MS Thiese, L Ivacic, MG Wesley, JM Lamberte, X Sun, ME Smith, AL Phillips, KD Groover, YM Yoo, J Gerald, RT Brown, MK Herring, G Joseph, S Beitel, TC Morrill, J Mak, P Rivers, KM Harris, DR Hunt, ML Arvay, P Kutty, AM Fry, M Gaglani

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading